Plant cannabinoids

Cannabidivarin

Definition: CHEBI:182159 · Chemical Entities of Biological Interest · release 253

45public articles

4registered condition areas

All documents →

Identity & provenance

Chemical identity

C19H26O2 · molecular weight 286.415

Sources: ChEBI · 253

0 referenced plant-occurrence records. They are identity candidates, not clinical evidence.

Experimental bioactivity

ChEMBL assay candidates

ChEMBL assay and bioactivity records are experimental candidates, not clinical facts, efficacy evidence or treatment recommendations. Showing 12 of 95 exact linked records.

Antagonist activity at human GPR55 expressed in HEK293 cells assessed as inhibition of LPI-induced beta-arrestin recruitment incubated 60 mins prior to LPI addition by beta-arrestin translocation assay

G-protein coupled receptor 55 · Homo sapiens

Activity = 56.0 % · candidate, not a clinical fact

Assay CHEMBL2388863 ↗ · Target CHEMBL1075322 ↗ · Source document ↗

Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay

SH-SY5Y · Homo sapiens

IC50 = 55000.0 nM · candidate, not a clinical fact

Assay CHEMBL4321398 ↗ · Target CHEMBL614910 ↗ · Source document ↗

Research areas

Conditions found alongside this compound

Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.

Epilepsy and cannabinoids

7 matching public articles

Candidate association · not a treatment claim

Chronic pain and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Multiple sclerosis and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Parkinson disease and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Linked local records

Medicines and registered studies

Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.

Medicines with this active ingredient

No public medicine record matched.

Registered studies

7 exact source-intervention matches.

Results postedTERMINATED

Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)

CBDV Compound

Protocol onlyRECRUITING

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Cannabidivarin

Protocol onlyCOMPLETED

Shifting Brain Excitation-Inhibition Balance Through the Endocannabinoid System in Men With Autism Spectrum Disorder (ASD) and in Healthy Controls

CBDV

Protocol onlyCOMPLETED

A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.

GWP42006

Protocol onlyCOMPLETED

A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.

GWP42006

Protocol onlyTERMINATED

Safety and Tolerability of GWP42006 in Children and Young Adults With Autism Spectrum Disorder

GWP42006

Protocol onlyUNKNOWN

Androgenetic Alopecia Treatment Using Varin and Cannabidiol-rich Topical Hemp Oil - A Case Series

Recent research

2026

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Drugs · Free full text · non-commercial reuse

2026

Integrative network analysis reveals organizational principles of the endocannabinoid system.

Journal of Cannabis Research · Free full text

2025

Evaluation of the Profile of Selected Bioactive Compounds and the Potential of Barley Wort Enriched with Malted and Unmalted Hemp Seeds for Brewing Applications.

Molecules · Free full text

2025

Uncovering the antifungal potential of Cannabidiol and Cannabidivarin.

PLOS Neglected Tropical Diseases · Free full text

2025

Potency Analysis of Semi-Synthetic Cannabinoids in Vaping Oils Using Liquid Chromatography Diode Array Detector with Electrospray Ionization Time-of-Flight Mass Spectrometry for Confirmation of Analyte Identity.

Molecules · Free full text

2025

The phytocannabinoid cannabidivarin alleviates cognitive and social behaviour deficits in the sub-chronic phencyclidine rat model of relevance for schizophrenia.

Journal of Psychopharmacology (Oxford, England) · Free full text

2025